Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures

Journal of the Neurological Sciences

Volumn 266, Issue 1-2, 2008, Pages 126-130

  Suenaga, Naoko ^a   Ichiyama, Takashi ^a   Kubota, Masaya ^b   Isumi, Hiroshi ^c   Tohyama, Jun ^d   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

Author keywords

Acute encephalopathy; Febrile seizure; Matrix metalloproteinase 9; Tissue inhibitors of metalloproteinases 1

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE BRAIN DISEASE; ANALYTIC METHOD; ARTICLE; BLOOD BRAIN BARRIER; CHILD; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPTIC STATE; FEBRILE CONVULSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PARALYSIS; PRIORITY JOURNAL; WEST SYNDROME;

BRAIN DISEASES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MATRIX METALLOPROTEINASE 9; PARALYSIS; SEIZURES, FEBRILE; SPASMS, INFANTILE; STATUS EPILEPTICUS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 38749095496     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.011     Document Type: Article

References (28)

1. Mizuguchi M., Yamanouchi H., Ichiyama T., and Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 (2007) 45-56
2. Ichiyama T, Suenaga N, Kajimoto M, Tohyama J, Isumi H, Kubota M., et al. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev in press.
3. Chandler S., Miller K.M., Clements J.M., Lury J., Corkill D., Anthony D.C., et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72 (1997) 155-161
4. Lukes A., Mun-Bryce S., Lukes M., and Rosenberg G.A. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 19 (1999) 267-284
5. Murphy G., and Knäuper V. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?. Matrix Biol 15 (1997) 511-518
6. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., and Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96 (1995) 2304-2310
7. Waubant E., Goodkin D.E., Gee L., Bacchetti P., Sloan R., Stewart T., et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53 (1999) 1397-1401
8. Avolio C., Ruggieri M., Giuliani F., Liuzzi G.M., Leante R., Riccio P., et al. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 136 (2003) 46-53
9. Dubois B., Leary S.M., Nelissen I., Opdenakker G., Giovannoni G., and Thompson A.J. Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1α. J Neurol 250 (2003) 1037-1043
10. Waubant E., Goodkin D., Bostrom A., Bacchetti P., Hietpas J., Lindberg R., et al. IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 60 (2003) 52-57
11. Yushchenko M., Mäder M., Elitok E., Bitsch A., Dressel A., Tumani H., et al. Interferon-β-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. J Neurol 250 (2003) 1224-1228
12. Blanco Y., Saiz A., Carreras E., and Graus F. Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis. J Neuroimmunol 153 (2004) 190-194
13. Karabudak R., Kurne A., Guc D., Sengelen M., Canpinar H., and Kansu E. Effect of interferon β-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results. J Neurol 251 (2004) 279-283
14. Mirowska D., Wicha W., Czlonkowski A., Czlonkowska A., and Weber F. Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. J Neuroimmunol 146 (2004) 171-175
15. Sastre-Garriga J., Comabella M., Brieva L., Rovira A., Tintore M., and Montalban X. Decreased MMP-9 production in primary progressive multiple sclerosis patients. Mult Scler 10 (2004) 376-380
16. Abraham M., Shapiro S., Karni A., Weiner H.L., and Miller A. Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells. J Neuroimmunol 163 (2005) 157-164
17. Rosenberg G.A. Matrix metalloproteinases biomarkers in multiple sclerosis. Lancet 365 (2005) 1291-1293
18. Ribatti D., Marimpietri D., Pastorino F., Brignole C., Nico B., Vacca A., et al. Angiogenesis in neuroblastoma. Ann N Y Acad Sci 1028 (2004) 133-142
19. Lee J.M., Yin K., Hsin I., Chen S., Fryer J.D., Holtzman D.M., et al. Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage. J Neurol Sci 229-230 (2005) 249-254
20. Ichiyama T., Kajimoto M., Suenaga N., Maeba S., Matsubara T., and Furukawa S. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. J Neuroimmunol 172 (2006) 182-186
21. Ichiyama T., Siba P., Suarkia D., Reeder J., Takasu T., Miki K., et al. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis. J Neurol Sci 252 (2007) 45-48
22. Ichiyama T., Morishima T., Kajimoto M., Matsushige T., Matsubara T., and Furukawa S. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 26 (2007) 542-544
23. Nelson K.B., and Ellenberg J.H. Febrile seizures (1981), Raven Press, New York
24. Takanashi J., Oba H., Barkovich A.J., Tada H., Tanabe Y., Yamanouchi H., et al. Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy. Neurology 66 (2006) 1304-1309
25. Yamanouchi H., Kawaguchi N., Mori M., Imataka G., Yamagata T., Hashimoto T., et al. Acute infantile encephalopathy predominantly affecting the frontal lobes. Pediatr Neurol 34 (2006) 93-100
26. Gastaut H., Poirier F., Payan H., Salamon G., Toga M., and Vigouroux M. H.H.E. syndrome; hemiconvulsions, hemiplegia, epilepsy. Eplepsia Ekp Khirurg 1 (1960) 418-447
27. Sellner J., and Leib S.L. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis 21 (2006) 647-656
28. Yamamoto S., and Nguyen J.H. TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure. J Surg Res 134 (2006) 307-314